TIM
RPTX

Tortoise Investment Management’s Repare Therapeutics RPTX Stock Holding History

Tortoise Investment Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-210
Closed -$3K – 788
2022
Q3 		$3K Hold
210
– – ﹤0.01% 659
2022
Q2 		$3K Hold
210
– – ﹤0.01% 658
2022
Q1 		$3K Hold
210
– – ﹤0.01% 623
2021
Q4 		$4K Hold
210
– – ﹤0.01% 570
2021
Q3 		$6K Buy
+210
New +$6.78K ﹤0.01% 512

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tortoise Investment Management's RPTX Position: Q4 2022 in Review

Tortoise Investment Management sold out of Repare Therapeutics (RPTX) in Q4 2022, closing a stake of 210 shares — an estimated $3K sold.

Tortoise Investment Management first reported a position in RPTX in Q3 2021 and held it in 5 quarters. The position peaked at $6K in Q3 2021. 82 funds tracked by Wall St. Rank hold RPTX as of Q4 2022.

  • Tortoise Investment Management reported no remaining Repare Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Tortoise Investment Management sold 210 Repare Therapeutics shares in Q4 2022, an estimated $3K.
  • Tortoise Investment Management first reported a position in Repare Therapeutics in Q3 2021 and held it in 5 quarters.
  • Tortoise Investment Management's Repare Therapeutics position peaked at $6K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2022.

Based on Tortoise Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.